|
|
Current progress on scaffolds of tissue engineering
heart valves |
DONG Nianguo1, SHI Jiawei1, CHEN Si1, HONG Hao1, HU Ping2 |
1.Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; 2.Institute of Polymer Science & Engineering, Tsinghua University; |
|
|
Abstract Tissue engineering heart valves (TEHV) may be the most promising valve substitute, but the study has been relatively stagnant in the recent five years due to the special position, function and mechanical property of heart valves. It is one of the key factors to select an ideal scaffold material in the construction of TEHV. And this article will briefly review the current research and progress on the scaffolds of TEHV, especially based on Chinese works.
|
Issue Date: 05 September 2008
|
|
1 |
Shinoka T, Breuer C K, Tanel R E, Zund G, Miura T, Ma P X, Langer R, Vacanti J P, Mayer J E Jr . Tissueengineering heart valves: valve leaflet replacement study in a lambmodel. Ann Thorac Surg, 1995, 60(6 Suppl): S513–516. doi:10.1016/0003‐4975(95)00733‐4
|
2 |
Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss R R, Pethig K, Haverich A, Bader A . Tissueengineering of pulmonary heart valves on allogenic acellular matrixconduits: in vivo restoration of valve tissue. Circulation, 2000, 102(19 Suppl 3): III50–55
|
3 |
Hoerstrup S P, Sodian R, Daebritz S, Wang J, Bacha E A, Martin D P, Moran A M, Guleserian K J, Sperling J S, Kaushal S, Vacanti J P, Schoen F J, Mayer J E Jr . Functional living trileaflet heart valvesgrown in vitro. Circulation, 2000, 102(19 Suppl 3): III44–49
|
4 |
O'Brien M F, Goldstein S, Walsh S, Black K S, Elkins R, Clarke D . TheSynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissueheart valve for autologous recellularization first experimental studiesbefore clinical implantation. Semin ThoracCardiovasc Surg, 1999, 11(4 Suppl 1): 194–200
|
5 |
Simon P, Kasimir M T, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E . Early failure of the tissue engineered porcine heartvalve Synergraft in pediatric patients. Eur J Cardiothorac Surg, 2003, 23(6): 1002–1006. doi:10.1016/S1010‐7940(03)00094‐0
|
6 |
Hu P . Surgicalimplants for tissue engineering and the processing, modification andapplication of biomaterials. Zhongguo YiliaoQixie Zazhi, 2006, 12(7): 13–21 (in Chinese)
|
7 |
Song Q, Shi J W, Dong N G, Sun Z Q . The progresson tissue engineering heart valves. ZhonghuaShiyan Waike Zazhi, 2003, 20(4): 381–383 (in Chinese)
|
8 |
Flanagan T C, Pandit A . Living artificial heart valvealternatives. Eur Cell Mater, 2003, 6(1): 28–45
|
9 |
Dong N G, Sun Z Q, Shi J W, Zund G . Experimentalconstruction of tissue engineering heart valves. Zhonghua Shiyan Waike Zazhi, 2002, 19(1): 88–90 (in Chinese). .
|
10 |
Boontheekul T, Mooney D J . Protein-based signaling systemsin tissue engineering. Curr Opin Biotechnol, 2003, 14(5): 559–565. doi:10.1016/j.copbio.2003.08.004
|
11 |
Dong N G, Ye X F, Shi J W, Song Q, Sun Z Q . Comparison on decellularizing approachesof biological scaffold with porcine aortic valve for tissue engineeringheart valve. Zhonghua Shiyan Waike Zazhi, 2005, 22(3): 377 (in Chinese)
|
12 |
Erdbrügger W, Konertz W, Dohmen P M, Posner S, Ellerbrok H, Brodde O E, Robenek H, Modersohn D, Pruss A, Holinski S, Stein-Konertz M, Pauli G . Decellularized xenogenicheart valves reveal remodeling and growth potential in vivo. Tissue Eng, 2006, 12(8): 2059–2068. doi:10.1089/ten.2006.12.2059
|
13 |
Lichtenberg A, Tudorache I, Cebotari S, Ringes-Lichtenberg S, Sturz G, Hoeffler K, Hurscheler C, Brandes G, Hilfiker A, Haverich A . Invitro re-endothelialization of detergent decellularized heart valvesunder simulated physiological dynamic conditions. Biomaterials, 2006, 27(23): 4221–4229. doi:10.1016/j.biomaterials.2006.03.047
|
14 |
Kasimir M T, Rieder E, Seebacher G, Nigisch A, Dekan B, Wolner E, Weigel G, Simon P . Decellularization does not eliminatethrombogenicity and inflammatory stimulation in tissue-engineeredporcine heart valves. J Heart Valve Dis, 2006, 15(2): 278–286
|
15 |
Rieder E, Kasimir M T, Silberhumer G, Seebacher G, Wolner E, Simon P, Weigel G . Decellularizationprotocols of porcine heart valves differ importantly in efficiencyof cell removal and susceptibility of the matrix to recellularizationwith human vascular cells. J Thorac CardiovascSurg, 2004, 127(2): 399–405. doi:10.1016/j.jtcvs.2003.06.017
|
16 |
Shi J W, Dong N G . Application of RGD peptidesin the field of tissue engineering. ZhonghuaShiyan Waike Zazhi, 2005, 22(9): 1150–1152 (in Chinese)
|
17 |
Bayless K J, Salazar R, Davis G E . RGD-dependent vacuolation and lumen formation observedduring endothelial cell morphogenesis in three-dimensional fibrinmatrices involves the alpha (v) beta (3) and alpha(5)beta(1) integrins. Am J Pathol, 2000, 156(5): 1673–1683
|
18 |
Stamm C, Khosravi A, Grabow N, Schmohl K, Treckmann N, Drechsel A, Nan M, Schmitz K P, Haubold A, Steinhoff G . Biomatrix/polymer compositematerial for heart valve tissue engineering.Ann Thorac Surg, 2004, 78(6): 2084–2092. doi:10.1016/j.athoracsur.2004.03.106
|
19 |
Stock U A, Vacanti J P, Mayer Jr J E, Wahlers T . Tissueengineering of heart valves - current aspects. Thorac Cardiovasc Surg, 2002, 50(3): 184–193. doi:10.1055/s‐2002‐32406
|
20 |
Schenke-Layland K, Riemann I, Opitz F, König K, Halbhuber K J, Stock U A . Comparative study of cellular and extracellular matrixcomposition of native and tissue engineered heart valves. Matrix Biol, 2004, 23(2): 113–125. doi:10.1016/j.matbio.2004.03.005
|
21 |
Shangguan Y Y, Wang Y W, Wu Q, Chen G Q . The mechanicalproperties and in vitro biodegradation and biocompatibility of UV-treatedpoly (3-hydroxybutyrate-co-3-hydroxyhexanoate). Biomaterials, 2006, 27(11): 2349–2357. doi:10.1016/j.biomaterials.2005.11.024
|
22 |
Lutolf M P, Hubbell J A . Synthetic biomaterials asinstructive extracellular microenvironments for morphogenesis in tissueengineering. Nat Biotechnol, 2005, 23(1): 47–55. doi:10.1038/nbt1055
|
23 |
Lutolf M P, Weber F E, Schmoekel H G, Schense J C, Kohler T, Müller R, Hubbell J A . Repair of bone defects using synthetic mimetics of collagenous extracellularmatrices. Nat Biotechnol, 2003, 21(5): 513–518. doi:10.1038/nbt818
|
24 |
Lutolf M P, Lauer-Fields J L, Schmoekel H G, Metters A T, Weber F E, Fields G B, Hubbell J A . Synthetic matrix metalloproteinase-sensitive hydrogels for the conductionof tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA, 2003, 100(9): 5413–5418. doi:10.1073/pnas.0737381100
|
25 |
Halstenberg S, Panitch A, Rizzi S, Hall H, Hubbell J A . Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradablebiosynthetic material for tissue repair. Biomacromolecules, 2002, 3(4): 710–723. doi:10.1021/bm015629o
|
26 |
Qi H X, Hu P, Xu J, Wang A J . Encapsulationof drug reservoirs in fibers by emulsion electrospinning: morphologycharacterization and preliminary release assessment. Biomacromolecules, 2006, 7(8): 2327–2330. doi:10.1021/bm060264z
|
27 |
Yoon K, Kim K, Wang X F, Fang D F, Hsiao B S, Chu B . Highflux ultrafiltration membranes based on electrospun nanofibrous PANscaffolds and chitosan coating. Polymer, 2006, 47(8): 2434–2441. doi:10.1016/j.polymer.2006.01.042
|
28 |
Hersel U, Dahmen C, Kessler H . RGD modified polymers: biomaterials for stimulated celladhesion and beyond. Biomaterials, 2003, 24(24): 4385–4415. doi:10.1016/S0142‐9612(03)00343‐0
|
29 |
Myles J L, Burgess B T, Dickinson R B . Modification of the adhesive properties of collagen bycovalent grafting with RGD peptides. JBiomater Sci Polym Ed, 2000, 11(1): 69–86. doi:10.1163/156856200743508
|
30 |
Yang D Z, Hao J . Surface modification of biomaterialswith poplypeptides. Guowai Yixue ShengwuYixue Gongcheng Fence, 2004, 27(2): 65–68 (in Chinese)
|
31 |
Shi J W, Dong N G, Sun Z Q . Immobilization of RGD peptides onto decellularized valvescaffolds to promote cell adhesion. J WuhanUniv Technol Mater Sci Ed, 2007, 22(4): 686–690. doi:10.1007/s11595‐006‐4686‐6
|
32 |
Shi J W, Dong N G, Sun Z Q, Qiu Y M . The roleof RGD peptides and transforming growth factor-β1 in TEHV construction. Zhonghua Yi XueZa Zhi, 2006, 86(29): 2074–2077 (in Chinese)
|
33 |
Dong N G, Qiu Y M, Shi J W . Applications of transforming growth factor - beta1 onconstruction of tissue engineering heart valves in vitro. Zhonghua Yi Xue Za Zhi, 2007, 87(23): 1622–1626 (in Chinese)
|
34 |
Hong H, Dong N G, Shi J W . Amplex Red fluorometric assay for detection of lysyloxidase in tissue engineered heart valve. Zhongguo Xiong Xin Xueguan Linchuang Zazhi, 2007, 14(1): 27–30 (in Chinese)
|
35 |
Dong N G, Ye X F, Sun Z Q, Shi J W, Qiu Y M, Chen J J . Experimental study on mechanical properties of decellularized porcineaortic valve and effects of precoating methods of biological scaffoldon histocompatibility. Zhonghua Wai KeZa Zhi, 2007, 45(16): 1128–1131 (in Chinese)
|
36 |
Mott J D, Werb Z . Regulation of matrix biologyby matrix metalloproteinases. Curr OpinCell Biol, 2004, 16(5): 558–564. doi:10.1016/j.ceb.2004.07.010
|
37 |
Shinoka T . Tissueengineered heart valves: autologous cell seeding on bio-degradablepolymer scaffold. Artif Organs, 2002, 26(5): 402–406. doi:10.1046/j.1525‐1594.2002.07004.x
|
38 |
Engelmayr G C Jr, Rabkin E, Sutherland F W, Schoen F J, Mayer J E Jr, Sacks M S . The independent role of cyclic flexure in the early in vitro development of an engineered heartvalve tissue. Biomaterials, 2005, 26(2): 175–187. doi:10.1016/j.biomaterials.2004.02.035
|
39 |
Sodian R, Hoerstrup S P, Sperling J S, Daebritz S, Martin D P, Moran A M, Kim B S, Schoen F J, Vacanti J P, Mayer J E Jr . Early in vivo experience with tissue-engineered trileaflet heartvalves. Circulation, 2000, 102(19 Suppl 3): III22–29
|
40 |
Davis M E, Hsieh P C, Grodzinsky A J, Lee R T . Custom designof the cardiac microenvironment with biomaterials. Circ Res, 2005, 97(1): 8–15. doi:10.1161/01.RES.0000173376.39447.01
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|